Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Enoxaparin for DVT Prophylaxis After Total Hip Arthroplasty
NCT02379663Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Jan 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rivaroxaban in deep vein thrombosis (DVT), sponsored by Samsung Medical Center. Started Jan 2012; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT02379663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379663.